TrialPanorama/TrialPanorama-database huggingface dataset:
Study: NCT05862844

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Promise women project (Promote Cervical Cancer Prevention Methods Among Muslim Women in Virginia )
Description: The Intervention Arm involves a 90-minute educational session tailored to Muslim women. They will learn about HPV infection risks, cervical cancer risks, and benefits of early screening and HPV vaccination. Discussions cover transmission, consequences, risk factors (behaviors, infections, family history), and importance of early detection. The session provides information on screening methods, check-ups, and HPV vaccine safety. Participants actively engage in discussions, ask questions, and share thoughts. The session empowers women with knowledge to make informed decisions about their health, promoting cervical cancer prevention.
Study: NCT05345951

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-PBI+
Description: The e-PBI+ is a preventive parent-based intervention emphasizing parent-teen communication on drinking/risks of alcohol abuse, with the addition of data-driven cannabis content to guide parent communications with their students (e.g., cannabis content focusing on the endocannabinoid system; acute and chronic cannabis use effects on the brain, cognition, and development; THC potency in present-day cannabis; cannabis use effects on mental and physical health, including psychosis, depression, and anxiety; respiratory/cardiovascular/sleep problems; cannabidiol (CBD) content, myths; and cannabis effects on psychosocial function). Together the goals are to reduce alcohol and cannabis use in college students.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: e-PBI
Description: The e-PBI is currently a model prevention resource at NIAAA's College Alcohol Intervention Matrix and the research was discussed in the most recent Surgeon General's Report as one of two prevention approaches that met the rigorous criteria to be considered efficacious. The first section of the e-PBI provides an introduction to the problem of substance use. The second section focuses on specific skill building strategies that parents can use to improve communication channels with their teen. Third is a section that addresses peer influence and provides strategies for developing assertiveness. The fourth section is an in-depth discussion of underage drinking, physiological and psychological effects, mixing alcohol with other drugs, motives for why students drink and don't drink, warning signs, risky binge-type drinking, impaired driving, riding with impaired drivers, alcohol and sexual assault, and how to communicate about parents' experiences when they were young.
Study: NCT05585489

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Gait training with musical cue
Description: Entraînement de 20 minutes de marche à vitesse confortable sur un parcours ovale de 20 mètres au laboratoire ARM avec la technique d'indiçage musical personnalisé de la longueur de pas.
Study: NCT05587023

Intervention type: PROCEDURE
Group type: PLACEBO_COMPARATOR
Intervention: stellate ganglion block
Description: The experimental group was given 6ml ropivacaine for stellate ganglion block. In the control group, 6ml saline was used for stellate ganglion block.

Intervention type: PROCEDURE
Group type: EXPERIMENTAL
Intervention: stellate ganglion block
Description: The experimental group was given 6ml ropivacaine for stellate ganglion block. In the control group, 6ml saline was used for stellate ganglion block.
Study: NCT05215938

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI examination
Description: The magnetic resonance imaging session will be performed in a clinical 3T MRI scanner (GE healthcare). A commercial human intent non-diagnostic RF coil (PulseTeq) will be used for 23Na MRI.~The scanner, coils and sequences are regularly used in research projects and validated for the same safety requirements as routinely used in the clinic. Nevertheless, the complete MRI session will be performed in research mode to use the advanced options (limits the usage to non-diagnostic purposes).~Participants will be placed in a supine position with coils covering the area of interest (AOF).~MRI examination will be performed by trained personnel.

Intervention type: DIAGNOSTIC_TEST
Intervention: MRI examination
Description: The magnetic resonance imaging session will be performed in a clinical 3T MRI scanner (GE healthcare). A commercial human intent non-diagnostic RF coil (PulseTeq) will be used for 23Na MRI.~The scanner, coils and sequences are regularly used in research projects and validated for the same safety requirements as routinely used in the clinic. Nevertheless, the complete MRI session will be performed in research mode to use the advanced options (limits the usage to non-diagnostic purposes).~Participants will be placed in a supine position with coils covering the area of interest (AOF).~MRI examination will be performed by trained personnel.
Study: NCT05393323

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physical therapy with distraction technique
Description: Distraction will be at suboccipital level and patients will ask to assume a supine position with the head on the plinth. The therapist will use fingertips in both hands from digits 2 through 5, and cups the suboccipital region of the patient and supports the posterior skull. The therapist provides a light distraction to the posterior skull. Distraction will be applied for 10 min with pull for 10 sec and5 sec will be applied. Prior to apply this technique all patients will receive 15 minutes of infrared with TENS at cervical spine. The total treatment session will be of 25 minute with total intervention period of 4 weeks with 5 sessions per week.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: conventional physical therapy with traction technique
Description: In cervical traction, patients will ask to lie supine on the treatment table. Head will cradle by physiotherapist from chin and the occiput, and then the physiotherapist will apply traction force in 25 degree neck flexion. Traction will be applied for 10 minutes with pull for 10 sec and 5 sec rest will be applied. Prior to apply this technique all patients will receive 15 minutes of infrared with TENS at cervical spine. The total treatment session will be of 25 min with total intervention period of 4 weeks with 5 sessions per week. All outcome measurements will be assessed before treatment and then reassessed at the end of 4th week.
Study: NCT04902911

Intervention type: DEVICE
Intervention: COVID-19 SARS-CoV IgG/IgM antibody rapid test
Description: Needle stick point of care and 3mL vial of blood will be collected and tested for individual without history of COVID-19 and immunization as well as a second group composed of individuals with history of COVID-19
Study: NCT05894655

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No-cost self-testing kit vending machines
Description: This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime. The vending machines will be available 24 hours/day, 7 days a week.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No-cost self-testing kit vending machines
Description: This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime. The vending machines will be available 24 hours/day, 7 days a week.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: No-cost self-testing kit vending machines
Description: This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime. The vending machines will be available 24 hours/day, 7 days a week.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: No-cost self-testing kit vending machines
Description: This strategy includes vending machines that will provide interactive instructions for accessing free self-testing COVID-19 kits located outside of clinics for patients and community members to use anytime. The vending machines will be available 24 hours/day, 7 days a week.
Study: NCT06534723

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Wujia Yizhi granules
Description: Drug: Wujia Yizhi granuless

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo
Study: NCT05246839

Intervention type: BEHAVIORAL
Intervention: Brief Video
Description: Videos about colorectal cancer screening.

Intervention type: BEHAVIORAL
Intervention: Brief Video Plus
Description: Videos about colorectal cancer screening and modalities.
Study: NCT05972564

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Empagliflozin 25 MG
Description: Empagliflozin is an FDA-approved SGLT2 inhibitor used for the treatment of type 2 diabetes, with off-label use for diabetic kidney disease and for heart failure with reduced ejection fraction even in those without diabetes.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo
Description: Placebo consists of gelatin capsules.
Study: NCT04543968

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: hydroxytyrosol (HT) intake
Description: MD patients will receive hydroxytyrosol (HT) daily as dietary supplements for 12 months. After that, patients will be randomly assigned in 1:1 ratio to continue on receiving hydroxytyrosol (HT) as their dietary supplements for another 6 months.

Intervention type: DIETARY_SUPPLEMENT
Group type: EXPERIMENTAL
Intervention: hydroxytyrosol (HT) intake and withdraw
Description: MD patients will receive hydroxytyrosol (HT) daily as dietary supplements for 12 months. After that, patients will be randomly assigned in 1:1 ratio to withdraw from receiving hydroxytyrosol (HT) as their dietary supplements for another 6 months.
Study: NCT05934838

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Tazemetostat Pill
Description: Participants will take 800 mg of tazemetostat twice a day starting 7 days before apheresis and continue to take tazemetostat until lymphodepletion, which is chemotherapy given prior to receiving the CAR T cells. Participants will stop taking tazemetostat after lymphodepletion until after CAR T cell infusion. Once lymphocyte counts increase, tazemetostat will be resumed and tazemetostat will be taken for 6 - 12 months, depending on participant response.
Study: NCT05083754

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Retifanlimab
Description: Anti-PD-1 Therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Retifanlimab
Description: Anti-PD-1 Therapy

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Temozolomide
Description: Anti-PD-1 Therapy

Intervention type: DRUG
Group type: OTHER
Intervention: Temozolomide
Description: Anti-PD-1 Therapy
Study: NCT06060444

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Telemedicine Consult
Description: Neurological consultation completed remotely

Intervention type: OTHER
Group type: OTHER
Intervention: In-person Consult
Description: Neurological consultation completed in-person
Study: NCT06519994

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Artesunate vaginal inserts
Description: Subjects will self-administer 200 mg of Artesunate vaginal insert daily for 5 days, on weeks 1, 3, 5.

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo vaginal inserts
Description: Subjects will self-administer a placebo vaginal insert daily for 5 days, on weeks 1, 3, 5.
Study: NCT05234658

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PHITAH
Description: Tissue Engineered Human Artificial Skin: Fibrin-Hyaluronic Acid

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: PHIT
Description: Human artificial skin created by tissue engineering: fibrin-agarose

Intervention type: BIOLOGICAL
Group type: ACTIVE_COMPARATOR
Intervention: Skin Autograft
Description: Skin Autograft
Study: NCT06457997

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: PHN-010
Description: PHN-010 is an ADC
Study: NCT05535972

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: FF/UMEC/VI
Description: FF/UMEC/VI will be administered in a single inhaler Trelegy Ellipta.
Study: NCT05083754

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Standard of Care

Intervention type: RADIATION
Group type: EXPERIMENTAL
Intervention: Radiation Therapy
Description: Standard of Care

Intervention type: RADIATION
Group type: OTHER
Intervention: Radiation Therapy
Description: Standard of Care
Study: NCT06317389

Intervention type: OTHER
Intervention: Questionnaires
Description: Patients will benefit of supervision by the ONCORAL team in the usual way and their intervention will be limited to completing questionnaires.
Study: NCT06229158

Intervention type: OTHER
Intervention: Sexual satisfaction questionnaire for patients
Description: Completion by patients of a 28-item ad-hoc questionnaire evaluating their sexual satisfaction, alone or with the help of one of the researchers.~Each item is rated using a Likert-type scale from 1 to 5. The maximum score is 140, the minimum score is 28. A low score reflects a good level of sexual satisfaction.~Participants who have agreed to take part in the qualitative part of the study will be contacted within a few days of inclusion to arrange an appointment for a semi-structured individual interview.

Intervention type: OTHER
Intervention: Sexual satisfaction questionnaire for patients' life partner
Description: Completion by the patients' life partner of a 30-item ad-hoc questionnaire evaluating their sexual satisfaction, alone or with the help of one of the researchers.~Each item is rated using a Likert-type scale from 1 to 5. The maximum score is 140, the minimum score is 28. A low score reflects a good level of sexual satisfaction.~Participants who have agreed to take part in the qualitative part of the study will be contacted within a few days of inclusion to arrange an appointment for a semi-structured individual interview.
Study: NCT06240065

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Green bean puree
Description: Green bean puree as a proxy for fiber-foods

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Green bean puree
Description: Green bean puree as a proxy for fiber-foods
Study: NCT06493409

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Repotrectinib
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Repotrectinib
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Voriconazole
Description: Specified dose on specified days

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Quinidine
Description: Specified dose on specified days
Study: NCT05380050

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal Management Training plus Attention Training
Description: GMT is a Power Point directed interactive group training to use a five point strategy to plan and execute complex tasks. Attention Training utilizes Brain HQ attention modules and individualized attention goals.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: Goal Management Training plus Attention Training
Description: GMT is a Power Point directed interactive group training to use a five point strategy to plan and execute complex tasks. Attention Training utilizes Brain HQ attention modules and individualized attention goals.

Intervention type: BEHAVIORAL
Group type: PLACEBO_COMPARATOR
Intervention: Brain Health Workshop and National Geographic Movies
Description: BHW is a Power Point directed interactive training to learn about the brain and cognitive components. National Geographic Movies, participants select movies to watch with the therapists and answers questions regarding the content.
Study: NCT05194202

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: ED-HEART
Description: Behavioral intervention that assesses 1) healthy and unhealthy relationship behaviors, 2) conversation with partners around boundaries within relationships, 3) harm reduction strategies, and 4) resources for Adolescent Relationship Abuse (ARA) and related concerns, including Point of Care (POC) Reproductive and Sexual Health (RSH) harm reduction resources.
Study: NCT06239844

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Experimental: Nav-Team
Description: Participants in this arm will receive additional assistance related to asthma, log encounters, complete surveys.
Study: NCT05361343

Intervention type: OTHER
Group type: OTHER
Intervention: 1. Nutrition; 2. Physical activity; 3. Hypoxic training; 4. Menthal heals improvement
Description: 1. Nutrition: intermittent fasting;~2. Physical activity: medium-intensity or high-intensity physical activity;~3. Hypoxic training (at least three per visit to the center);~4. correction of hygiene and sleep duration, relaxation techniques, cognitive behavioral therapy for insomnia.~5. Individual motivational counseling.
Study: NCT04776304

Intervention type: BEHAVIORAL
Group type: OTHER
Intervention: Art Therapy
Description: This is a pilot study in which every participant receives the art therapy intervention arm. There are no waitlist or control arms. Art therapy is one promising intervention that helps service members (SMs) develop a visual voice, using imagery, symbolism, and metaphor to externalize emotions and experiences that they may not be able to express in words. The standardized, integrative mental health and human services approach of the art therapy program at the NICoE utilizes a mask-making directive to explore thoughts, feelings, and experiences of combat and self-understanding. This process is especially relevant to SMs with PTS symptoms who often remember their trauma as an incoherent, fragmented memory that is often predominantly sensory in nature. NICoE researchers have provided preliminary evidence suggesting associations between recurring art themes represented within the masks and individual BH symptoms.
Study: NCT06641466

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimegepant
Description: Rimegepant 75 mg ODT for 7 days

Intervention type: DRUG
Group type: PLACEBO_COMPARATOR
Intervention: Placebo Comparator
Description: Matching placebo oral disintegrating tablets for 7 days

Intervention type: DRUG
Group type: ACTIVE_COMPARATOR
Intervention: Standard of Care
Description: Standard of care for acute treatment as needed

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: Rimegepant
Description: Rimegepant 75 mg ODT for acute treatment as needed
Study: NCT05715320

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CM310
Description: IL-4Rα monoclonal antibody

Intervention type: BIOLOGICAL
Group type: EXPERIMENTAL
Intervention: CM310
Description: IL-4Rα monoclonal antibody
Study: NCT06384352

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YL211
Description: Patients will be treated with YL211 intravenous (IV) infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YL211
Description: Patients will be treated with YL211 intravenous (IV) infusion.

Intervention type: DRUG
Group type: EXPERIMENTAL
Intervention: YL211
Description: Patients will be treated with YL211 intravenous (IV) infusion.
Study: NCT06371378

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PEEP 0
Description: PEEP 0 CMH20 will be used During Surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PEEP 4
Description: PEEP 4 CMH20 will be used During Surgery

Intervention type: PROCEDURE
Group type: ACTIVE_COMPARATOR
Intervention: PEEP 8
Description: PEEP 8 CMH20 will be used During Surgery
Study: NCT05855759

Intervention type: OTHER
Group type: ACTIVE_COMPARATOR
Intervention: Acellular Dermal Matrix
Description: Patinets will be treated with acellular dermal matrix with standard arthroscopic technique performed as per normal clinical practice. For the tendon repair the acellular dermal matrix patch will be placed over the repaired tendon with dedicated sutures and anchors.

Intervention type: OTHER
Group type: EXPERIMENTAL
Intervention: Acellular Dermal Matrix with autologous orthobiologics
Description: Patinets will be treated with acellular dermal matrix enriched with autologous humeral bone marrow concentrate and subacromial bursa with standard arthroscopic technique. Humeral bone marrow concentrate will be harvested from the proximal humeral head inthe operating room and concentrated by an automatic close system.
Study: NCT05253196

Intervention type: DEVICE
Group type: EXPERIMENTAL
Intervention: Use of the foley catheter assistive device
Description: All participants will use the foley catheter assistive device when performing their daily enema
Study: NCT05421494

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: written exposure therapy-revised version
Description: WET-R is a manualized exposure-based therapy program consisting of 5-7 sequential individual sessions. The interval between every 2 consecutive sessions is 0-3 days. There will be 5-7 one to one online sessions in total (only one index trauma will be discussed), and 1-3 weeks to complete. Sessions are scheduled to last for 1 hour in the first session and 50 minutes in other sessions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: written exposure therapy-revised version
Description: WET-R is a manualized exposure-based therapy program consisting of 5-7 sequential individual sessions. The interval between every 2 consecutive sessions is 0-3 days. There will be 5-7 one to one online sessions in total (only one index trauma will be discussed), and 1-3 weeks to complete. Sessions are scheduled to last for 1 hour in the first session and 50 minutes in other sessions.

Intervention type: BEHAVIORAL
Group type: EXPERIMENTAL
Intervention: written exposure therapy-revised version
Description: WET-R is a manualized exposure-based therapy program consisting of 5-7 sequential individual sessions. The interval between every 2 consecutive sessions is 0-3 days. There will be 5-7 one to one online sessions in total (only one index trauma will be discussed), and 1-3 weeks to complete. Sessions are scheduled to last for 1 hour in the first session and 50 minutes in other sessions.
Study: NCT06581120

Intervention type: DRUG
Intervention: Glucagon-Like Peptide-1 receptor agonists
Description: GLP-1 RAs: Glucagon like peptide-1 receptor agonists, this includes patients who are on Liraglutide, Semaglutide, Dulaglutide and Tirzepatide.Tirzepatide which is a combined GLP-1 RA/glucose-dependent insulinotropic polypeptide (GIP) agonist is included as a part of GLP-1 RAs.